Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Case Reports in Ophthalmology ; 14(1):23-28, 2023.
Article in English | ProQuest Central | ID: covidwho-2297447

ABSTRACT

This report describes a case of a newly diagnosed 49-year-old HIV patient, who presented with decreased visual acuity and retinal lesions characterized by ischemia at the level of the deep retinal capillary plexus, documented with optical coherence tomography (OCT), OCT angiography, fluorescein angiography, and visual fields testing. These lesions closely resembled the morphologic and clinical characteristics of late paracentral acute middle maculopathy. The presence of these lesions suggests that HIV microangiopathy can potentially affect both superficial and deep retinal capillary plexuses.

2.
J Mycol Med ; 32(2): 101236, 2022 May.
Article in English | MEDLINE | ID: covidwho-1586953

ABSTRACT

Candida kefyr (Kluyveromyces marxianus), an ascomycetous environmental yeast, occasionally isolated from dairy products, represents an uncommon but emerging pathogen in immunocompromised patients. Herein, we present a case of C. kefyr pyelonephritis in a 41-year-old, previously immunocompetent, patient who was hospitalized in an COVID-19 ICU. Pyelonephritis was associated with caliectasis and obstruction due to possible fungus ball formation. Predisposing factors included ICU stay, use of broad spectrum antibiotics and steroids, central venous catheterization, mechanical ventilation and urologic manipulation. Susceptibility testing revealed high MIC values to amphotericin B. Infection was effectively controlled by prolonged administration of fluconazole without further surgical intervention. COVID-19 complicated with invasive candidiasis is an increasingly observed clinical situation that warrants high suspicion index and careful evaluation of laboratory data.


Subject(s)
COVID-19 , Candidiasis, Invasive , Pyelonephritis , Adult , Antifungal Agents/therapeutic use , COVID-19/complications , Candida , Candidiasis , Candidiasis, Invasive/diagnosis , Candidiasis, Invasive/drug therapy , Fluconazole/therapeutic use , Humans , Intensive Care Units , Kluyveromyces , Pyelonephritis/diagnosis , Pyelonephritis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL